Deuruxolitinib Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 8 mg
Reference Brands: Leqselvi (USA/EU)
Category: Derma Drugs
Deuruxolitinib is an oral Janus kinase (JAK) inhibitor used for the treatment of severe alopecia areata. It works by blocking JAK signaling pathways that drive autoimmune inflammation responsible for hair loss. Leqselvi helps promote hair regrowth in patients with extensive scalp and eyebrow involvement through targeted immune modulation. Deuruxolitinib is available in Tablets and strengths such as 8 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Deuruxolitinib is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Deuruxolitinib can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Deuruxolitinib is used for treating adults with severe Alopecia Areata, an autoimmune condition where the immune system attacks hair follicles, causing significant hair loss.
Deuruxolitinib is a synthetic small‑molecule Janus kinase (JAK) inhibitor, designed to block JAK1 and JAK2 enzymes to modulate immune signaling.
The trade name of Deuruxolitinib is Leqselvi.
Leqselvi (Deuruxolitinib) is manufactured and marketed by Sun Pharmaceutical Industries.
The generic name is Deuruxolitinib.
The brand name is Leqselvi.
Leqselvi is manufactured by Sun Pharmaceutical Industries.
Related Products
Acitretin
Strength:
10 mg, 17.5 mg, 22.5 mg, 25 mg
Form: Capsules
Reference Brands: Soriatane (USA), Neotigason (EU)
View Details
Mafenide
Strength:
10% w/w
Form: Creams
Reference Brands: Sulfamylon(USA), Flamazine (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
